Emergence of Covid-19 and High Prevalence of Congenital Heart Disease in Infants to Augment Growth of Fetal and Neonatal Monitoring Market
Fetal
and neonatal monitoring is a technique of monitoring your newborn's heart and
lungs before, during, and after he/she was born. Normally the mother passes all
of her body functions to the baby via vaginal deliveries or breastfeeding. A
monitor is inserted into the birth canal to detect any irregularities in
breathing, heartbeat, or pumping. These monitors are also used in early
detection of any problems associated with your unborn baby such as congenital
heart disease, breathing difficulties, or infections.
Market Dynamics
High
prevalence of congenital heart disease in infants is expected to propel growth
of the fetal and neonatal monitoring market. For instance, according to the
study, Prevalence, profile, and pattern of congenital heart disease in Central India:
A prospective, observational study (published in May 2018), the prevalence of
congenital heart disease (CHD) was 10.13/1000 live births. Moreover, emergence
of Covid-19 is also expected to aid in growth of the market. For instance, in
July 2020, Koninklijke Philips N.V. launched Avalon CL Fetal and Maternal Pod
and Patch capable of providing “continuous non-invasive monitoring” of
important vital signs such as maternal heart rate, fetal heart rate, and
uterine activity.
High
rate of maternal mortality in emerging economies is expected to offer lucrative
growth opportunities for players in the fetal and neonatal
monitoring market. For instance, according to Maternal Mortality: 1990 to
2015 Estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations
Population Division, Sub-Saharan Africa recorded the highest ratio or maternal
mortality, at 555 per 100, 000 live births, from 1990 to 2015. Moreover, the
United Nations is focused on achieving the Sustainable Development Goals 2015 -
2030 global maternal mortality ratio target of less than 70 per 100 000 live
births.
Among regions, North America is expected to witness
significant growth in the fetal and neonatal
monitoring market, owing to increasing
preterm birth rate in the U.S. For instance, according to March of Dimes 2019
report card, the preterm birth rate in the U.S. reached 10.02% in 2018 from 9.63%
in 2015.
Competitive Analysis
Major
players operating in the fetal and neonatal monitoring market include, Becton,
Dickinson and Company, Fujifilm SonoSite Inc., Medtronic Plc, Dragerwerk AG
& Co. KGAA, Cooper Surgical, Getinge AB, MindChild Medical, Inc., Natus
Medical Incorporated, GE Healthcare, Siemens Healthcare GmbH, ArjoHuntleigh,
Inc., Neoventa Medical, Koninklijke Philips N.V., Analogic Corporation,
Spacelabs Healthcare Inc., Smiths Medical, and Masimo.
Major
players operating in the fetal and neonatal monitoring market are focused on
adopting partnership strategies to enhance their market share. For instance, in
April 2019, Henry Schein Medical, the U.S. Medical business of Henry Schein,
Inc., and MindChild Medical, Inc. signed an exclusive distribution and supply
agreement for the MERIDIAN M110 Fetal Monitoring System.
Comments
Post a Comment